Zimmer Biomet Acknowledges 11 Observations in Form 483

As noted by leadership in its 1Q18 earnings call, FDA performed an inspection of Zimmer Biomet's Warsaw North Campus manufacturing facility which concluded on April 24, 2018. FDA issued a Form 483 with 11 inspectional observations. None identified specific performance issues with any product, and all products continue to be manufactured in the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us